SCHEMBL3958495

SCHEMBL3958495

CCCCc1nc2ccccn2c(=O)c1-c1cccc(NC2CCN(C(=O)O)C2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.40
AGTR2 P50052 1/20 0.40
MAPT P10636 3/20 0.39
GFER P55789 1/20 0.38
ALDH1A1 P00352 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SPR P35270 1/20 0.37
TLR8 Q9NR97 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
LMNA P02545 1/20 0.36
RXFP1 Q9HBX9 5/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3961800 0.91 AGTR1 (0.43) AGTR1AGTR2MAPTGFERALDH1A1
SCHEMBL3961041 0.90 USP30 (0.41) ALDH1A1L3MBTL1
SCHEMBL3955647 0.88 MAPT (0.40) AGTR1AGTR2MAPTGFERALDH1A1
SCHEMBL3958483 0.87 AGTR1 (0.40) AGTR1AGTR2MAPTALDH1A1L3MBTL1
SCHEMBL3961045 0.86 GFER (0.49) AGTR1AGTR2MAPTGFERRXFP1
SCHEMBL3963579 0.86 AGTR1 (0.44) AGTR1AGTR2MAPTGFERALDH1A1
SCHEMBL3961647 0.86 GFER (0.44) AGTR1AGTR2MAPTGFERALDH1A1
SCHEMBL3965077 0.86 SYK (0.40) AGTR1AGTR2MAPTGFERALDH1A1
SCHEMBL5132270 0.83 HTR6 (0.41) AGTR1AGTR2MAPTALDH1A1LMNA
SCHEMBL3958607 0.82 GFER (0.45) GFERALDH1A1L3MBTL1SPRRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079737-A1 PYRIDOPYRIMIDINONE COMPOUNDS USEFUL IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2009-07-22 EP claimed
WO-2008097991-A1 PYRIDOPYRIMIDINONE COMPOUNDS USEFUL IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-14 WO claimed
EP-2079737-A1 PYRIDOPYRIMIDINONE COMPOUNDS USEFUL IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2009-07-22 EP disclosed
WO-2008097991-A1 PYRIDOPYRIMIDINONE COMPOUNDS USEFUL IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-14 WO disclosed